SCHEMBL7653451

SCHEMBL7653451

COc1ccc(C(=O)Nc2ccc3c(c2C)CN(C)CC3(C)C)cc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
PDE4D Q08499 1/20 0.41
BRAF P15056 10/20 0.40
RAF1 P04049 3/20 0.40
CYP2C19 P33261 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
LMNA P02545 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650280 0.90 MAPT (0.45) MAPTPDE4DBRAFRAF1CYP2C19
SCHEMBL7658656 0.90 MAPT (0.41) MAPTPDE4DBRAFRAF1CYP2C19
SCHEMBL7654988 0.89 PDE4D (0.41) MAPTPDE4DBRAFRAF1CYP2C19
SCHEMBL7652077 0.88 PDE4D (0.39) MAPTPDE4DBRAFRAF1CYP2C19
SCHEMBL6602603 0.83 HDAC8 (0.46) MAPTPDE4DBRAFRAF1SMN1; SMN2
SCHEMBL7658508 0.83 MAPT (0.42) MAPTPDE4DBRAFRAF1CYP2C19
SCHEMBL7989876 0.81 MAPT (0.47) MAPTBRAFRAF1CYP2C19KDM4E
SCHEMBL7658777 0.78 NPC1 (0.54) MAPTCYP2C19KDM4EMEN1CYP2D6
SCHEMBL7650138 0.78 MAPT (0.50) MAPTCYP2C19KDM4EMEN1CYP2C9
SCHEMBL7659468 0.77 MAPT (0.52) MAPTCYP2C19KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492378-B1 Substituted isoquinoline derivatives and their use as anticonvulsivants SMITHKLINE BEECHAM P.L.C. (GB) 2002-12-10 US claimed
EP-1104404-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2001-06-06 EP claimed
WO-2000009486-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSIVANTS SMITHKLINE BEECHAM P.L.C. (GB) 2000-02-24 WO claimed
US-6492378-B1 Substituted isoquinoline derivatives and their use as anticonvulsivants SMITHKLINE BEECHAM P.L.C. (GB) 2002-12-10 US disclosed
EP-1104404-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2001-06-06 EP disclosed
WO-2000009486-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSIVANTS SMITHKLINE BEECHAM P.L.C. (GB) 2000-02-24 WO disclosed